Considerations To Know About Ago tumor
Molecular typing is based on molecular genetic screening and isn't nevertheless routinely readily available. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-67 could be handy,